Module 1 - Administrative information application form
Person signing the application form should have a letter of authorisation for communication/signing on behalf of the applicant (to be attached in annex 5.4). 1. Type of application 1.1. This application concerns 1.1.1. A Centralised Procedure Article 3 of Regulation (EC) No 726/2004 defines the eligibility of applications for evaluation under the
Download Module 1 - Administrative information application form
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Revealed: 50 million Facebook profiles harvested for ...
freestudio21.comhas passed it to the National Crime Agency’s cybercrime unit and the Information Commissioner’s Office. It includes emails, invoices, contracts and bank transfers that reveal more than 50 million profiles – mostly belonging to registered US voters – were harvested from the site in one of the largest-ever breaches of Facebook data. Facebook
The supply of unlicensed medicinal products (“specials”)
assets.publishing.service.gov.ukthe Licensing Authority. This may take the form of a prescriber’s letter, however an alternative fully documented audit trail through the supply chain confirming special need may be acceptable. 2.4 Although MHRA does not recommend “off-label” (outside the licensed indications) use
Trailer registration numbers and number plates
assets.publishing.service.gov.ukVehicle Licensing Agency (DVLA). This applies to: • all commercial use trailers that weigh over 750kg ... plate authorisation certificate to the RNPS. We ... black characters (the letter and numbers) on a white background. The characters and the surface of the
Nitrosamines EMEA-H-A5(3)-1490 - Information on ...
www.ema.europa.euAn agency of the European Union ... Information on nitrosamines for marketing authorisation holders . Request to evaluate the risk of the presence of nitrosamine impurities in human medicinal products containing chemically synthesised active pharmaceutical ingredients .
Guidelines for Control of Cosmetic Products in Malaysia
www.npra.gov.myLetter of Authorisation (LOA) / Letter of Declaration A Letter of Authorisation (LOA) is issued by the product owner including the list of products or brands authorising the CNH to notify the products with the NPRA and be responsible for all matters pertaining to product notification if the CNH is not the product owner.
E13 Photo Kit - transport.wa.gov.au
www.transport.wa.gov.au• A confirmation of electoral enrolment letter issued by the Australian Electoral Commission (less than two years old). • An official document or letter from a Government Agency with current residential address (for example the Australian Taxation Office, Centrelink or Medicare) that is less than six months old.